Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast (FACT-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03812393
Recruitment Status : Recruiting
First Posted : January 23, 2019
Last Update Posted : October 12, 2020
Sponsor:
Collaborators:
Celcuity
Puma Biotechnology, Inc.
Information provided by (Responsible Party):
West Cancer Center